[shaunattwood]

2 big volume breakouts from Friday SSNC & CAG
some others with interesting volume:
GLPI, BLKB, SQBG, DPLO, PF, SUM

[shaunattwood]

Big Pharma buyouts are set to be at a record level this year. With that in mind, I've looked at the graphs and come up with five possible candidates based on price and volume action. Any thoughts on the symbols below please?
AMPH, ZTS, MDSO, MYL, PRGO

[pcabc]

CAG, a gap up:
   

RPM - not strictly Weinstein, looks like it is potentially going to make a continuation. Volume drying up remarkably:
   

---

Big Pharma buyouts are set to be at a record level this year. With that in mind, I've looked at the graphs and come up with five possible candidates based on price and volume action. Any thoughts on the symbols below please?
AMPH, ZTS, MDSO, MYL, PRGO

My likely non-optimal view.

AMPH, I'd assume it should have been snagged at the start of the month when it broke above 16.

ZTS, to me late in the day. Run up from 32 to 50. Relative stength nice but not seeing the volume.

MDSO, new stage 1 base? This is exactly the sort of thing I buy too early...

PRGO, very interesgting. I'm rubbish at guessing the bottoms of pullbacks.

TXMD may also be worth a look. I'm wondering though about caution regarding market breadth - is now the time. I'm bad at holding back.

---

TXMD may also be worth a look. I'm wondering though about caution regarding market breadth - is now the time. I'm bad at holding back.

Add BRMN, NMC.L (healthcare - hospitals not biotech)

---

Something significant has happened with WMB, up over 25%, nearly breaking out:
   

[shaunattwood]

3 biotechs just came up my radar:
SRNE perhaps best one as big volume + at breakout level (not overbought)
NDRM lacks volume but at all time high + cup & handle pattern?
EPZM huge volume yesterday but perhaps too much overhead resistance
any thoughts? i'm quite liquid right now having cashed out of FEYE & CYBR thanks isa and pcabc (awaiting to rebuy on pullbacks)

[pcabc]

3 biotechs just came up my radar:
SRNE perhaps best one as big volume + at breakout level (not overbought)
NDRM lacks volume but at all time high + cup & handle pattern?
EPZM huge volume yesterday but perhaps too much overhead resistance
any thoughts? i'm quite liquid right now having cashed out of FEYE & CYBR thanks isa and pcabc (awaiting to rebuy on pullbacks)

Not that I'm an expert...

SRNE - In stage 2 passing resistance from the middle of last year. However, where do you put the stop loss? The MA30w/MA150d is about 35% below the current price. Previous low could be 50% down.

NDRM - Only just getting a hint of MA30. About to make a continuation. A long way above the average.

EPZM - Might be about to make a base. Average might have levelled off. Has not had a higher low yet.

I've noticed another biotechs making a continuations, NVAX:
   

I've put some other biotechs into my screener but it will take a while to get the number crunching done. I'm a bit worried by market breadth - we are not clraly pulling out of the latest general pullback.

[shaunattwood]

I agree pcabc, but Stan said the exceptional winners breakout after having big runups like SRNE. With that in mind I'm buying partial positions.
bought 300 at 17 today
and will buy 300 more if it drops $1 etc
building up to 1200 shares
but if market averages turn bearish (nasdaq below 150 day ma) or if SRNE breaks trendline from recent rally ($14) and heads for 50 day ma, I'll dump it all

[pcabc]

I agree pcabc, but Stan said the exceptional winners breakout after having big runups like SRNE. With that in mind I'm buying partial positions.
bought 300 at 17 today
and will buy 300 more if it drops $1 etc
building up to 1200 shares
but if market averages turn bearish (nasdaq below 150 day ma) or if SRNE breaks trendline from recent rally ($14) and heads for 50 day ma, I'll dump it all

I've not been through the turn to a proper stage 4 market. The UK definitely had a wobble in 2014 and I was loosing money churning through picks that failed. Although the stage analysis is fairly mechanistic there is still some room for judgement. I can see your position. Truth be told I am fully invested and if I weren't then I can't honestly say whether I'd be sitting on cash rather than seriously looking at some more positions.

I put a number of biotechs into my screener last night. A few buys can be picked out, good ones like you have but I also have a lot in stage 4 or perhaps turning to stage 1 or in stage 1. I don't know whether that is significant, they might or might not be small caps and I don't know how much that should influence things.

[shaunattwood]

Just 2 on my radar from yesterday, but perhaps yesterday's down day was a good relative strength stress test.
IXYS - semiconductor company breaking out to a 12 year high with volume on the back of a 50%+ run up, so satisfies Stan's Uncovering Exceptional Winners status.
MOMO - Chinese social media with volume pulling back from $20 and with a cash buyout offer at $18.9 v $17.22 current price

pcabc - biotech sector index BTK is still in a raging bull mode, you can use big charts industry analyzer to look at the whole sector's charts rated by market cap using this link: http://bigcharts.marketwatch.com/industr...undredDays